By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Health > Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
Health

Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call

GlobeNews Wire
Last updated: 14/08/2025 12:36 AM
GlobeNews Wire
Published: 14/08/2025
Share
SHARE

August 13, 2025 11:45 ET  | Source: Milestone Scientific, Inc.

ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:00 AM Eastern Time on Friday, August 15th, 2025, to discuss the company’s financial results for the second quarter ended June 30, 2025, as well as the company’s corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 470429. A webcast and replay of the call may be accessed at Webcast URL: https://www.webcaster4.com/Webcast/Page/2306/52876.

An audio replay of the call will be available through Friday, August 29th, 2025, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and by entering the access code: 52876.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS), a technology-focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.

Contact:
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020

Kotak Gen2Gen Income Wins Product of the Year 2025 Award
NYSE Content Advisory: Pre-market update + U.S. & EU reach trade deal
Strategic Optimism Amid Domestic Stability: Small Businesses Recalibrate Plans in Response to Evolving Demand and Profitability Trends – ASSOCHAM Dun & Bradstreet Small Business Confidence Index
Firstsource recognized as a ‘Leader’ for the second consecutive year in Avasant’s Mortgage Business Process Transformation 2025 RadarView
Tredence Named Snowflake Partner of the Year for Retail & CPG at Snowflake Summit 2025
TAGGED:2025andBusinesscallconferencefinancialmilestonenewsNYSE:MLSSquarterresultsschedulesscientificsecondupdateUS59935P2092
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Meiyume at Cosmopack Asia 2025: SEEDED — Rooted in Intelligence, Connected Through the Beauty Vein
News

Meiyume at Cosmopack Asia 2025: SEEDED — Rooted in Intelligence, Connected Through the Beauty Vein

28/10/2025
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI IQLIK(lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease Under Fast Track Status
Lamborghini announces the Polo Storico Tour to celebrate 60 years of the Miura during Auto Moto dEpoca
BrightSpring Announces Pricing of Secondary Offering of Common Stock
Olympic history at the IOC: Thomas Bach passes presidency to Kirsty Coventry
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?